An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 8 Sponsors

Jun 10, 2026 · House

Referred to Judiciary

Jun 9, 2026 · Senate

Third consideration and final passage

Jun 8, 2026 · Senate

Re-reported as committed

Jun 3, 2026 · Senate

Second consideration

Jun 3, 2026 · Senate

Re-referred to Appropriations

Jun 2, 2026 · Senate

Reported as committed

Jun 2, 2026 · Senate

First consideration

Jul 24, 2025 · Senate

Referred to Agriculture & Rural Affairs

PASSAGE PROBABILITY

4.8% Unlikely

Why this number

Stage base Passed First Chamber — base rate 19%, measured from PA's completed sessions
Momentum +2 60/100 from the pace of recorded action
Time since last action -17 123 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.